Drug-Eluting Stent ThrombosisResults From the Multicenter Spanish Registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos)
José M. de la Torre-Hernández, MD, PhD*,*,
Fernando Alfonso, MD, PhD ,
Felipe Hernández, MD ,
Jaime Elizaga, MD ,
Marcelo Sanmartin, MD, PhD||,
Eduardo Pinar, MD¶,
Iñigo Lozano, MD, PhD#,
Jose M. Vazquez, MD**,
Javier Botas, MD, PhD ,
Armando Perez de Prado, MD ,
Jose M. Hernández, MD, PhD ,
Juan Sanchis, MD, PhD||||,
Juan M. Ruiz Nodar, MD, PhD¶¶,
Alfredo Gomez-Jaume, MD, PhD##,
Mariano Larman, MD***,
Jose A. Diarte, MD, PhD  ,
Javier Rodríguez-Collado, MD  ,
Jose R. Rumoroso, MD, PhD  ,
Jose R. Lopez-Minguez, MD||||||,
Josepa Mauri, MD¶¶¶ for the ESTROFA Study Group
* Hospital Marques de Valdecilla, Santander, Spain
Hospital Clinico San Carlos, Madrid, Spain
Hospital 12 de Octubre, Madrid, Spain
Hospital Gregorio Marañon, Madrid, Spain
|| Hospital do Meixoeiro, Vigo, Spain
¶ Hospital Virgen de la Arrixaca, Murcia, Spain
# Hospital Central de Asturias, Oviedo, Spain
** Hospital Juan Canalejo, La Coruña, Spain
 Hospital Fundación Alcorcon, Alcorcon, Spain
 Hospital de Leon, Leon, Spain
 Hospital Virgen de la Victoria, Malaga, Spain
|||| Hospital Clínico, Valencia, Spain
¶¶ Hospital General, Alicante, Spain
## Hospital Son Dureta, Palma de Mallorca, Spain
*** Policlínica Guipúzcoa, San Sebastián, Spain
  Hospital Miguel Servet, Zaragoza, Spain
  Hospital Clinico, Salamanca, Spain
  Hospital de Galdacano, Bilbao, Spain
|||||| Hospital Infanta Cristina, Badajoz, Spain
¶¶¶ Hospital Germans Trias i Pujol, Badalona, Spain.

View larger version (9K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 1 Cumulative Incidence of ST
A Kaplan-Meier curve shows the survival free of definite stent thrombosis (ST) for the overall cohort and the subsequent cumulative incidence of ST. This incidence was 1.2%, 1.6%, and 2% at 1, 2, and 3 years, respectively.
|
|
|